CAH Panel 7 (21‑Hydroxylase Deficiency Therapeutic Monitoring)
Use
This panel is intended for therapeutic monitoring of patients with congenital adrenal hyperplasia due to 21‑hydroxylase deficiency, assessing steroid hormones relevant to adrenal function and response to steroid replacement therapy.
Special Instructions
An early morning specimen is preferred. Specify time of day specimen was collected, patient age and sex on test requisition. Transport in refrigerated condition using cold packs.
Limitations
Not provided.
Methodology
Mass Spectrometry
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
3 mL
Minimum Volume
0.4 mL
Container
red‑top tube (no gel)
Collection Instructions
An early morning specimen is preferred. Specify time of day specimen was collected, patient age and sex on test requisition.
Causes for Rejection
Gross hemolysis • Grossly lipemic • Received room temperature • Serum separator tube (SST)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 7 days |
| Frozen | 2 years |